维普中文期刊产品整合服务
12篇 您的检索式:作者名="Andersen KR"
    题名 作者 年代 出处 被引量
1Comparison ofempagliflozin and glimepiride as add-on to metformin inpatients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind* phase 3 trial 显示文摘Ridderstrale M Andersen KR Zeller C 2014Lancet DiabetesEndocrinol2014,2,9:1
2Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer显示文摘Andersen M Schnnemann KR Yilmaz M 2010Acta Oncol2010,49,8:1
3Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility显示文摘Andersen TI Heimdal KR Skrede M 1994Hum Genet1994,94,6:1
4Oestrogen receptor(ESR) polymorphism and breast cancer susceptibility 显示文摘Andersen TI Heimdal KR Skrede M 1994Hum Gent1994,94,6:1
5Comparison of empagliflozin and glimepiride as add-on to mefformin in patients with type 2 diabetes: a 104-week randomised, active- controlled, double-blind, phase 3 trial显示文摘RidderstrMe M Andersen KR Zeller C 2014Lancet Diabetes Endocrinol2014,2,9:1
6Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes : a 104-week randomised, active-controlled, double-blind, phase 3 trial 显示文摘Ridderstr~le M Andersen KR 2014Lancet Diabetes Endocrinol2014,2,9:1
7The modulation of Amyotrophic Lateral Sclerosis risk by Ataxin-2 intermediate polyglutamine expansions is a specific effect显示文摘Suzana Gispert Alexander Kurz Stefan Waibel Peter Bauer Inga Liepelt Christof Geisen Aaron D. Gitler Tim Becker Markus Weber Daniela Berg Peter M. Andersen Rejko Krüger Olaf Riess Albert C. Ludolph Georg Auburger 2011Neurobiology of Disease2011,,1:1
8Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility 显示文摘Andersen TI Heimdal KR Skrede M 1994Hum Genet1994,94,6:1
9Com- parison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active- controlled, double-blind, phase 3 trial显示文摘RIDDERSTR/~LE M ANDERSEN KR ZELLER C 2014Lancet Diabetes Ea- docrinol2014,2,9:1
10Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility 显示文摘Andersen TI Heimdal KR Skrede M 1994Hum Genet1994,94,6:1
11Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility 显示文摘Andersen TI Heimdal KR Skrede M 1994Hmn Genet1994,94,6:1
12Rethinking neurodegenerative diseases:neurometabolic concept linking lipid oxidation to diseases in the central nervous system显示文摘Currently,there is a lack of effective medicines capable of halting or reve rsing the progression of neurodegenerative disorde rs,including amyotrophic lateral sclerosis,Parkinson s disease,multiple sclerosis,or Alzheimer s disease.Given the unmet medical need,it is necessary to reevaluate the existing para digms of how to to rget these diseases.When considering neurodegenerative diseases from a systemic neurometabolic perspective,it becomes possible to explain the shared pathological features.This innovative approach presented in this paper draws upon exte nsive research conducted by the authors and researchers worldwide.In this review,we highlight the importance of metabolic mitochondrial dysfunction in the context of neurodegenerative diseases.We provide an overview of the risk factors associated with developing neurodegenerative disorders,including genetic,epigenetic,and environmental fa ctors.Additionally,we examine pathological mechanisms implicated in these diseases such as oxidative stress,accumulation of misfolded proteins,inflammation,demyelination,death of neurons,insulin resistance,dysbiosis,and neurotransmitter disturbances.Finally,we outline a proposal for the restoration of mitochondrial metabolism,a crucial aspect that may hold the key to facilitating curative therapeutic interventions for neurodegenerative disorders in forthcoming advancements.Steinunn Sara Helgudóttir Anne Skøttrup Mørkholt Jacek Lichota Preben Bruun-Nyzell Mads Christian Andersen Nanna Marie Juhl Kristensen Amanda Krøger Johansen Mikela Reinholdt Zinn Hulda Maria Jensdóttir John Dirk Vestergaard Nieland 2024Neural Regeneration Research2024,19,7:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费